Sale by Natarajan Sethuraman (President, Research & Develop.)
25,907 shares · @ $15.39 · $398,810
Entrada Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $6.91
-57% in 3d after detection
Post-detection moves
1h
—
1d
-0.3%
3d
-57%
7d
-54%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS